EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |